2nd Annual Immuno-Oncology BD&L and Investment Forum
Hyatt Chicago Magnificent Mile
June 3, 2016
CEO Dr. Daniel Teper to present at 12 PM
The 2nd Annual Immuno-Oncology: BD&L and Investment Forum is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering and funding & investment. We expect around 250 delegates and about 30 presentations by listed and private biotechnology companies seeking licensing & investment. Numerous networking opportunities available via an online One-2-One meeting system with dedicated meeting facilities to make the event more transactional.